Details
Groprinosin INDICATIONS
- infectious disease of viral etiology in patients with normal and reduced immune status: influenza, parainfluenza, respiratory catarrh; bronchitis, viral etiology, rhinovirus and adenovirus infections;
- mumps, measles;
- diseases caused by herpes simplex virus Herpes simplex type I, or Herpes simplex type II (herpes of the lips, skin, oral mucosa, skin, hands, ophthalmoherpes), subacute sclerosing panencephalitis, genital herpes;
- disease caused by the virus Varicella zoster (chickenpox and shingles, including recurrent in immunocompromised patients); Epstein - Barr virus (infectious mononucleosis);
- cytomegalovirus;
- human papillomavirus;
- acute and chronic viral hepatitis B;
- chronic recurrent respiratory tract infections and urinary tract in patients with weakened immune systems (including chlamydia and other diseases caused by intracellular pathogens).
APPLICATION
Inside, better after eating and at regular intervals; if necessary, the tablet can be chewed, crushed and / or dissolved in a small amount of water immediately before use. Duration of treatment is determined individually depending on the nosology, the severity of the process and the frequency of relapses; the average duration of treatment - 5-14 days, if necessary, after 7-10-day break, repeat the treatment; treatment interruptions and maintenance doses can last from 1 to 6 months.
The maximum daily dose for adults - 4 g (8 tablets of 500 mg).
CONTRAINDICATIONS
- sensitivity to the active ingredient or any of the excipients of the formulation;
- acute gout;
- hyperuricemia.
